22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/01/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
90 |
| 03/01/22 | 8-K | Current report filing |
|
|
34 |
| 02/04/22 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 |
